New study tracks aHUS patients in china to improve future care

NCT ID NCT06099236

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times

Summary

This study watches how Chinese patients with a rare kidney disease called aHUS are treated in real-world clinics. Researchers will follow 367 children and adults for up to 12 months to see what treatments they receive and how their health changes. The goal is to learn more about the disease and current care patterns, not to test a new drug.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATYPICAL HEMOLYTIC UREMIC SYNDROME(AHUS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Beijing, Beijing Municipality, China

  • Research Site

    Chongqing, Sichuan, China

  • Research Site

    Anhui, China

  • Research Site

    Beijing, China

  • Research Site

    Chongqing, China

  • Research Site

    Fujian, China

  • Research Site

    Guangdong, China

  • Research Site

    Guangxi, China

  • Research Site

    Guizhou, China

  • Research Site

    Hainan, China

  • Research Site

    Hebei, China

  • Research Site

    Henan, China

  • Research Site

    Hong Kong, China

  • Research Site

    Hubei, China

  • Research Site

    Hunan, China

  • Research Site

    Jiangsu, China

  • Research Site

    Jiangxi, China

  • Research Site

    Liaoning, China

  • Research Site

    Shaanxi, China

  • Research Site

    Shandong, China

  • Research Site

    Shanghai, China

  • Research Site

    Shanxi, China

  • Research Site

    Sichuan, China

  • Research Site

    Tianjin, China

  • Research Site

    Xinjiang, China

  • Research Site

    Zhejiang, China

Conditions

Explore the condition pages connected to this study.